Literature DB >> 7053668

Pharmacokinetics, pharmacodynamics, and dose-response relationships of pancuronium in control and elderly subjects.

P Duvaldestin, J Saada, J L Berger, A D'Hollander, J M Desmonts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7053668     DOI： 10.1097/00000542-198201000-00008

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  18 in total

Review 1.  Clinical pharmacokinetics of the newer neuromuscular blocking drugs.

Authors:  D P Atherton; J M Hunter
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of neuromuscular blocking drugs.

Authors:  S Agoston; R H Vandenbrom; J M Wierda
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

Review 3.  A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.

Authors:  R R Jaklitsch; D R Westenskow
Journal:  J Clin Monit       Date:  1990-01

4.  General anaesthesia in elderly patients with cardiovascular disorders: choice of anaesthetic agent.

Authors:  Sangeeta Das; Kirsty Forrest; Simon Howell
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

Review 5.  Neuromuscular transmission and its pharmacological blockade. Part 4: Use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

6.  Accelerated onset of pancuronium with divided doses.

Authors:  W G Doherty; P J Breen; F Donati; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1985-01

Review 7.  Selecting neuromuscular-blocking drugs for elderly patients.

Authors:  Tristan M Cope; Jennifer M Hunter
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Pharmacokinetics of pancuronium in patients undergoing coronary artery surgery with and without low dose dopamine.

Authors:  J M Wierda; P J van der Starre; A H Scaf; W D Kloppenburg; J H Proost; S Agoston
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

9.  Pharmacokinetics and pharmacodynamics of vecuronium bromide.

Authors:  T Nomura
Journal:  J Anesth       Date:  1992-01       Impact factor: 2.078

10.  Pharmacokinetic and pharmacodynamic modelling with pancuronium.

Authors:  M A Evans; C A Shanks; K F Brown; E J Triggs
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.